Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20130341Phase 3Terminated
A Phase 3 trial of chidantong in brain infarction, ischemic stroke, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Nov 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20130341.